Arrayit Corporation (ARYC)

Market Cap	2.25K
Revenue (ttm)	2.82M
Net Income (ttm)	-6.53M
Shares Out	1.13B
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,800
Average Volume	725,669
Open	0.0000
Previous Close	n/a
Day's Range	0.0000 - 0.0000
52-Week Range	0.0000 - 0.0000
Beta	-20.43
RSI	46.30
Earnings Date	n/a

About CTI BioPharma

Arrayit Corporation, a life sciences technology company, develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation, biological function, and diagnostics worldwide. The company is involved in the development and support of microarray tools and components; custom printing and analysis of microarrays for research; and the identification and development of diagnostic microarrays and tools for early detection of treatable disease states. It offers microarray printing technology, which allows ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• CEO: Rene Schena
• Employees: 7
• Stock Exchange: OTCMKTS
• Ticker Symbol: ARYC

Financial Performance

In 2014, Arrayit's revenue was $4.38 million, an increase of 50.83% compared to the previous year's $2.90 million. Losses were -$3.32 million, 768.2% more than in 2013.